Top compounds associated with response to RILP


Feature Type Standardized
Nominal ANOVA
mRNA NVP-BSK805 CTRPv2 pan-cancer AAC 0.18 4e-08
mRNA Nilotinib GDSC1000 pan-cancer AAC 0.2 7e-08
mRNA ruxolitinib CTRPv2 pan-cancer AAC 0.18 1e-07
mRNA Imatinib CTRPv2 pan-cancer AAC 0.19 1e-07
mRNA Fumonisin B1 CTRPv2 pan-cancer AAC 0.19 2e-07
mRNA PD-0332991 GDSC1000 pan-cancer AAC 0.17 1e-06
mRNA PD-0325901 GDSC1000 pan-cancer AAC 0.16 2e-06
mRNA CI-1040 GDSC1000 pan-cancer AAC 0.16 2e-06
mRNA 17-AAG GDSC1000 pan-cancer AAC 0.15 3e-06
mRNA ciclopirox CTRPv2 pan-cancer AAC -0.15 4e-06
Download CSV